US Patent 10856926 Neuromodulation for metabolic conditions or syndromes
Patent 10856926 was granted and assigned to Metavention on December, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 6, 2018
Date of Patent
December 8, 2020
Patent Applicant
Patent Application Number
16123308
Patent Citations
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10856926 Neuromodulation for metabolic conditions or syndromes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
